The National Oncologic PET Registry, which that now includes more than 300,000 patients [ 146 , 147 ], provided evidence for a highly significant impact of 18 F-FDG PET on patient management across a wide variety of cancers.
1
—
—
The National Oncologic PET Registry, which that now includes more than 300,000 patients [ 146 , 147 ], provided evidence for a highly significant impact of 18 F-FDG PET on patient management across a wide variety of cancers.